CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 64 filers reported holding CTI BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $163 | -27.9% | 38,723 | +3.0% | 0.00% | – |
| Q4 2022 | $226 | -99.9% | 37,593 | +4.6% | 0.00% | – |
| Q3 2022 | $210,000 | +21.4% | 35,939 | +23.8% | 0.00% | – |
| Q2 2022 | $173,000 | +35.2% | 29,039 | +6.0% | 0.00% | – |
| Q1 2022 | $128,000 | +58.0% | 27,400 | -16.2% | 0.00% | – |
| Q4 2021 | $81,000 | -15.6% | 32,700 | 0.0% | 0.00% | – |
| Q3 2021 | $96,000 | +17.1% | 32,700 | 0.0% | 0.00% | – |
| Q2 2021 | $82,000 | -13.7% | 32,700 | 0.0% | 0.00% | – |
| Q1 2021 | $95,000 | – | 32,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Legal & General Group Plc | 9,340 | $84,901 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 92,700 | $389,340 | 0.00% |
| FNY Investment Advisers, LLC | 20 | $0 | 0.00% |